Keywords: pulmenary arterial hypertension, Actelion, Ventavis

US FDA clears new formulation of Actelion’s Ventavis

Article | 10 August 2009

Print This

Actelion, a major European biotechnology firm based in Switzerland, says that the US Food and Drug Administration has approved a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in